Belpointe Asset Management LLC Exact Sciences Corp Transaction History

Belpointe Asset Management LLC

  • $1.49 Billion
  • Q3 2024

A detailed history of Belpointe Asset Management LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Belpointe Asset Management LLC holds 61,756 shares of EXAS stock, worth $3.06 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
61,756
Previous 71,837 14.03%
Holding current value
$3.06 Million
Previous $3.04 Million 38.52%
% of portfolio
0.28%
Previous 0.24%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$42.43 - $70.83 $427,736 - $714,037
-10,081 Reduced 14.03%
61,756 $4.2 Million
Q2 2024

Aug 02, 2024
BUY
$41.33 - $74.26 $1.26 Million - $2.27 Million
30,592 Added 74.17%
71,837 $3.04 Million
Q1 2024

May 08, 2024
BUY
$56.27 - $73.77 $1.11 Million - $1.46 Million
19,775 Added 92.11%
41,245 $2.85 Million
Q4 2023

Feb 13, 2024
BUY
$59.06 - $75.72 $937,695 - $1.2 Million
15,877 Added 283.87%
21,470 $1.59 Million
Q3 2023

Nov 15, 2023
BUY
$65.94 - $99.04 $203,886 - $306,231
3,092 Added 123.63%
5,593 $381,000
Q2 2023

Aug 14, 2023
SELL
$62.68 - $95.05 $5.2 Million - $7.88 Million
-82,953 Reduced 97.07%
2,501 $234,000
Q1 2023

May 15, 2023
SELL
$47.19 - $70.77 $90,746 - $136,090
-1,923 Reduced 2.2%
85,454 $5.79 Million
Q4 2022

Feb 08, 2023
BUY
$30.35 - $53.15 $1.15 Million - $2.02 Million
37,981 Added 76.89%
87,377 $4.33 Million
Q3 2022

Nov 14, 2022
BUY
$31.97 - $49.37 $1.46 Million - $2.25 Million
45,533 Added 1178.7%
49,396 $1.61 Million
Q2 2022

Aug 02, 2022
SELL
$35.61 - $76.23 $3,454 - $7,394
-97 Reduced 2.45%
3,863 $152,000
Q1 2022

Apr 28, 2022
BUY
$57.56 - $82.54 $44,896 - $64,381
780 Added 24.53%
3,960 $277,000
Q4 2021

Feb 15, 2022
BUY
$72.5 - $100.68 $77,792 - $108,029
1,073 Added 50.93%
3,180 $247,000
Q3 2021

Nov 15, 2021
BUY
$90.24 - $124.05 $9,655 - $13,273
107 Added 5.35%
2,107 $201,000
Q2 2021

Aug 09, 2021
BUY
$93.66 - $139.27 $92,255 - $137,180
985 Added 97.04%
2,000 $248,000
Q1 2021

May 14, 2021
SELL
$116.57 - $155.01 $170,541 - $226,779
-1,463 Reduced 59.04%
1,015 $134,000
Q4 2020

Feb 16, 2021
SELL
$99.61 - $142.12 $21,914 - $31,266
-220 Reduced 8.15%
2,478 $329,000
Q3 2020

Nov 13, 2020
SELL
$72.92 - $102.01 $16,552 - $23,156
-227 Reduced 9.56%
2,148 $125,000
Q3 2020

Nov 13, 2020
BUY
$72.92 - $102.01 $40,106 - $56,105
550 Added 25.61%
2,698 $275,000
Q2 2020

Jul 20, 2020
BUY
$55.75 - $92.75 $12,655 - $21,054
227 Added 10.57%
2,375 $207,000
Q1 2020

Jul 20, 2020
BUY
$37.9 - $104.44 $28,008 - $77,181
739 Added 52.45%
2,148 $125,000
Q4 2019

Feb 18, 2020
BUY
$77.66 - $99.74 $109,422 - $140,533
1,409 New
1,409 $130,000

Others Institutions Holding EXAS

# of Institutions
671
Shares Held
163M
Call Options Held
2.58M
Put Options Held
2.19M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $8.77B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Belpointe Asset Management LLC Portfolio

Follow Belpointe Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belpointe Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belpointe Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email